Application based on analyses from the Phase 3 CheckMate -8HW clinical trial, in which Opdivo plus Yervoy demonstrated superior progression-free survival compared to Opdivo monotherapy and investigator’s choice of chemotherapy The U.S. Food and Drug Administration assigned a target action date of June 23, 2025 PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #CRC—  U.S. Food and Drug Administration Accepts … [Read more…]

Almirall’s net sales growth in 2024 was 10.2% YoY (total of €985.7 MM) with EBITDA growth of 10.6% YoY (total of €192.6 MM) – surpassing guidance for the year with all key growth drivers delivering double digit growth. Company revenue growth continues to be driven by the strong performance of the European Dermatology business (+22.5% … [Read more…]

LEXINGTON, Mass.–(BUSINESS WIRE)–Proffered Papers, Session 2, Session Date and Time of release dated February 12, 2025, should read: Monday, February 24th, 1:39-1:45 p.m. PST (instead of Tuesday, February 25th, 1:00-1:45 p.m. PST). The updated release reads: AGENUS’ BOT/BAL SELECTED FOR TWO PRESENTATIONS AT UPCOMING AACR IO ANNUAL MEETING Agenus Inc. (Nasdaq: AGEN), a leader in … [Read more…]

Avtozma® (CT-P47), a biosimilar referencing RoActemra® (tocilizumab) is approved by the European Commission (EC) for all indications of the reference product1 EC approval is based on a comprehensive data package demonstrating Avtozma®’s biosimilarity to RoActemra®2,3 Celltrion’s biosimilar portfolio continues to grow, expanding treatment options to meet the needs of people with immune diseases INCHEON, South … [Read more…]

KKR to be the largest and controlling shareholder MUMBAI, India–(BUSINESS WIRE)–KKR, a leading global investment firm, and Healthcare Global Enterprises (BSE: 539787; NSE: HCG; “HCG”), a leading healthcare organization in India, today announced the signing of definitive agreements with CVC, a leading global private markets manager, under which funds managed by KKR (“KKR”) will become … [Read more…]

TORONTO–(BUSINESS WIRE)–Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) (“Predictmedix” or the “Company”), a leading provider of AI-powered health screening solutions, is pleased to announce the successful closing of the first tranche of its non-brokered private placement. The Company issued 16,000,000 units (“Units”) at an issue price of $0.02 per Unit, raising gross proceeds … [Read more…]

SEATTLE–(BUSINESS WIRE)–Know Labs, Inc. (previously NYSE American: KNW, now OTC Pink Markets: KNWN), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS), announced today the cancellation of the Special Meeting of Stockholders previously scheduled for March 7, 2025 (Special Meeting), which was intended to seek approval for a reverse stock … [Read more…]

LEANDER, Texas–(BUSINESS WIRE)–With profound sadness, Leaf Health announces the passing of our founder, CEO, and dear friend, Robert Shelley, after a courageous battle with cancer and its complications. For more than 30 years, Rob dedicated his career to improving access to and cost management of prescription drugs in the pharmacy benefits space. In 2017, he … [Read more…]

Patients, plasma donors, health care professionals, and community advocates are working together to address barriers to source plasma donations and help save more lives. SACRAMENTO, Calif.–(BUSINESS WIRE)–The California Plasma Coalition (CalPlasma) today launched a statewide campaign to raise awareness of the vital role that plasma donations play in saving lives of Californians and patients around … [Read more…]

MISSISSAUGA, Ontario–(BUSINESS WIRE)–Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 first quarter results for the period ended December 31, 2024 along with a number of important recent achievements and highlights. “Covalon achieved strong revenue growth, driven by the success of our US … [Read more…]